Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AB-BIOTICS

Explore full profile

Innovative probiotics with robust clinical evidence for health and wellness solutions

Barcelona, SpainFounded 2004Biotech & Life Sciences
Valuation $10–25M Last recorded · 2026
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for AB-BIOTICS and the history behind them.

At a glance

Founded
2004
Headquarters
Barcelona, Spain
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

87.2% KANEKA EUROPE HOLDING COMPANY NV
  • 6%
  • 6%

Some investors are hidden on this public profile. “Other / undisclosed” is the 0.8% not attributed to a named shareholder. See the full cap table on Dealroom →

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇪🇸 Spain · Barcelona HQ
Book a demo for the full country breakdown
Web traffic by country
5.3K monthly visits
across markets
🇺🇸 United States52.8%
🇮🇳 India24.5%
🇪🇸 Spain15.1%
🇦🇷 Argentina5.7%
🇬🇧 United Kingdom1.9%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about AB-BIOTICS on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AB-BIOTICS on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.